A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study

NCT05862285 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Ipatasertib
DRUG: Tiragolumab
DRUG: Atezolizumab
DRUG: Tiragolumab and Atezolizumab
DRUG: Bevacizumab
DRUG: Entrectinib
DRUG: Inavolisib
DRUG: Divarasib

Sponsor

Hoffmann-La Roche